BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18250475)

  • 1. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis.
    Jurynczyk M; Jurewicz A; Raine CS; Selmaj K
    J Immunol; 2008 Feb; 180(4):2634-40. PubMed ID: 18250475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of activated Notch signalling in collagen II-specific T helper type 1 (Th1)- and Th17-type expansion involving Notch3 and Delta-like1.
    Jiao Z; Wang W; Xu H; Wang S; Guo M; Chen Y; Gao J
    Clin Exp Immunol; 2011 Apr; 164(1):66-71. PubMed ID: 21235539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
    Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
    Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis.
    Salek-Ardakani S; So T; Halteman BS; Altman A; Croft M
    J Immunol; 2005 Dec; 175(11):7635-41. PubMed ID: 16301673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
    Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G
    PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21.
    Minter LM; Turley DM; Das P; Shin HM; Joshi I; Lawlor RG; Cho OH; Palaga T; Gottipati S; Telfer JC; Kostura L; Fauq AH; Simpson K; Such KA; Miele L; Golde TE; Miller SD; Osborne BA
    Nat Immunol; 2005 Jul; 6(7):680-8. PubMed ID: 15991363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.
    Tan SL; Zhao J; Bi C; Chen XC; Hepburn DL; Wang J; Sedgwick JD; Chintalacharuvu SR; Na S
    J Immunol; 2006 Mar; 176(5):2872-9. PubMed ID: 16493044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
    Saxena N; Won J; Choi S; Singh AK; Singh I
    Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis.
    Sandy AR; Stoolman J; Malott K; Pongtornpipat P; Segal BM; Maillard I
    J Immunol; 2013 Aug; 191(4):1606-13. PubMed ID: 23825310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
    J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.
    Wongchana W; Lawlor RG; Osborne BA; Palaga T
    J Immunol; 2015 Dec; 195(11):5337-46. PubMed ID: 26503951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis.
    Yeh WI; McWilliams IL; Harrington LE
    J Immunol; 2011 Nov; 187(10):4998-5006. PubMed ID: 21984703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
    PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
    Mohindru M; Kang B; Kim BS
    J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling augments T cell responsiveness by enhancing CD25 expression.
    Adler SH; Chiffoleau E; Xu L; Dalton NM; Burg JM; Wells AD; Wolfe MS; Turka LA; Pear WS
    J Immunol; 2003 Sep; 171(6):2896-903. PubMed ID: 12960312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}.
    Rao PE; Petrone AL; Ponath PD
    J Immunol; 2005 Feb; 174(3):1446-55. PubMed ID: 15661903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.
    Schmidt CS; Zhao J; Chain J; Hepburn D; Gitter B; Sandusky G; Chintalacharuvu S; Glasebrook A; Na S
    J Immunol; 2005 Aug; 175(4):2286-92. PubMed ID: 16081797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
    Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX
    J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.